Tag: life sciences
-
University, Company Employ AI for Anti-Aging Drugs
The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging.
-
Gene Editing, Therapy Company Gains $83.5M in Venture Funds
A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round.
-
Synthetic Beating Heart Repair Tissue Being Developed
A bioengineering team is developing a synthetic patch that contracts and sends electrical signals to repair heart muscle tissue after a heart attack.
-
Nerve Stimulation Shown to Relieve TBI Symptoms
Stimulation of a main cranial nerve is shown in tests with lab rodents to relieve additional symptoms and complications in severe traumatic brain injuries.
-
Engineered Viruses Studied to Improve Plant Traits.
A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought.
-
FDA Clears Algorithm-Assisted Cancer Diagnosis
The U.S. Food and Drug Administration cleared for marketing a diagnostics system aided by machine learning algorithms to help radiologists detect breast cancer.
-
Exosuit Shown to Improve Walking for Stroke Patients
A robotic device built and worn like clothing helps improve lower-limb walking performance for a group of people partially paralyzed with stroke.
-
RNA Vaccine for Rabies Found Safe, Generates Antibodies
A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies.
-
Tough Ingested Hydrogels Designed for Long-Term Drugs
A medical engineering team developed and tested in animals a new water-based polymer material to deliver drugs for long-term release in the stomach.
-
Takeda, Biosurfaces Partner on Nanofiber Devices
Takeda Pharmaceutical Company is joining with a developer of medical devices from nanoscale bioactive fibers to design new devices for gastrointestinal, or GI, disorders.